Myeloproliferative Neoplasms in the Young: Mayo Clinic Experience With 361 Patients Age 40 Years or Younger

Results from a Mayo Clinic study show that MPN patients age 40 and younger had longer median survival estimates than older patients with MPNs across all three disease types: polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

 American Journal of Hematology

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.